1 – 10 of 97
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
ESMO Clinical Practice Guideline interim update on the use of targeted therapy in acute lymphoblastic leukaemia
(
- Contribution to journal › Article
-
Mark
Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology : a post hoc analysis of the “ADAMANT” randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial
(
- Contribution to journal › Article
-
Mark
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies
(
- Contribution to journal › Article
-
Mark
Therapeutic Effects of IL-1RA against Acute Bacterial Infections, including Antibiotic-Resistant Strains
(
- Contribution to journal › Article
-
Mark
Targeting the stressed tumor niche of glioblastoma: Tumor microenvironment and surface antigens
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Fine tuning of the innate and adaptive immune responses by Interleukin-2
(
- Contribution to journal › Article
-
Mark
IL-2-mediated hepatotoxicity : knowledge gap identification based on the irAOP concept
(
- Contribution to journal › Article
-
Mark
Biomarkers in mesothelioma and non-small cell lung cancer - Investigation of cytological specimens with correlation to histology
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Empowering macrophages : the cancer fighters within the tumour microenvironment in mantle cell lymphoma
(
- Contribution to journal › Article
-
Mark
Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer’s disease
(
- Contribution to journal › Article